Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Afrezza
Afrezza Image

Afrezza

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Afrezza?

Afrezza is an innovative brand-name insulin product that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of both type 1 and type 2 diabetes. It is unique in its delivery method, as it comes in the form of an inhalable powder rather than the traditional injectable liquid. This dry powder insulin is inhaled through the lungs using a special inhaler device. Upon inhalation, the fine insulin powder is absorbed into the bloodstream, allowing it to start working quickly to help regulate blood sugar levels. Afrezza is intended for use in combination with long-acting insulin in individuals with type 1 diabetes. For those with type 2 diabetes, it can be used along with oral diabetes medications or other injectable insulin. It's important to note that Afrezza is not a substitute for long-acting insulin and is not recommended for the treatment of diabetic ketoacidosis. As with any medication, there are potential side effects, including a decrease in lung function, cough, and throat irritation. Afrezza is generally prescribed by healthcare professionals who will carefully determine the appropriate dose and usage regimen based on individual needs and circumstances. Regular monitoring of blood sugar levels is essential when using this medication to ensure optimal diabetes management.

How to use Afrezza?

Afrezza is an inhaled insulin product that is used to control blood sugar levels in individuals with type 1 diabetes and type 2 diabetes. It offers an alternative to traditional insulin injections. Here's how to use Afrezza: 1. Preparation: Before using Afrezza, it is important to check the cartridge to ensure it is not damaged or expired. If the cartridge is damaged or expired, do not use it. Wash your hands thoroughly before handling the inhaler. 2. Inhaler assembly: Attach the cartridge to the inhaler by gently sliding it into the designated area until it clicks into place. Do not force it. The inhaler is now ready for use. 3. Inhalation technique: Hold the inhaler in a horizontal position with the mouthpiece pointing towards you. Breathe out completely and place the mouthpiece between your lips, forming a tight seal. Take a deep breath and inhale quickly and deeply through the mouth, filling your lungs with air. 4. Administering the dose: After inhaling, hold your breath for as long as comfortable, usually about 5 seconds, then exhale. This ensures that the insulin is absorbed into your bloodstream properly. Repeat these steps if your healthcare provider has prescribed more than one dose. 5. Storage and care: Store Afrezza at room temperature, away from direct heat and light. It is essential to clean the inhaler regularly to prevent clogging. Follow the manufacturer's instructions on how to clean and maintain the device. 6. Follow instructions: Always follow your healthcare provider's instructions on how and when to use Afrezza. It is essential to monitor your blood sugar levels regularly and communicate with your healthcare team regarding any concerns or adjustments needed to your treatment plan. Remember, Afrezza is a prescription medication, so be sure to consult your healthcare provider for personalized guidance and adjustment of your diabetes management plan.

Afrezza is an inhaled insulin medication used for the management of both type 1 and type 2 diabetes. While it can be effective in controlling blood sugar levels, there are certain warnings associated with its use that should be considered. One of the main warnings is related to the risk of acute bronchospasm, which is a sudden constriction of the airways. People with asthma or chronic obstructive pulmonary disease (COPD) may be at a higher risk of experiencing this side effect. It is important to inform your healthcare provider if you have a history of lung disorders before starting treatment with Afrezza. Another warning is the potential for hypoglycemia or low blood sugar. This can occur if the insulin dose is too high or if there is a mismatch between the insulin dosage and carbohydrate intake. Symptoms of hypoglycemia include dizziness, sweating, confusion, and shakiness. It is important to regularly monitor blood sugar levels while using Afrezza and to follow your healthcare provider's instructions regarding dosing and meal planning. Additionally, Afrezza should not be used in individuals who smoke or have recently quit smoking, as it may increase the risk of bronchospasm. It is crucial to discuss your medical history and any concerns with your healthcare provider before starting Afrezza to ensure its safe and appropriate use.

Before taking Afrezza, it is important to be aware of certain warnings and precautions associated with this medication. Afrezza is a brand-name insulin product that is indicated for the treatment of both type 1 diabetes and type 2 diabetes. Firstly, it's important to note that Afrezza should NOT be used in cases of diabetic ketoacidosis, as it may worsen the condition. Additionally, Afrezza is contraindicated in individuals who have chronic lung disease, such as asthma or chronic obstructive pulmonary disease (COPD), as it may cause acute bronchospasm or worsen existing lung issues. Another important warning is that Afrezza carries a risk of hypoglycemia, or low blood sugar. It is essential to closely monitor blood sugar levels while taking this medication and take appropriate measures to treat low blood sugar if it arises. Symptoms of hypoglycemia include dizziness, shakiness, confusion, sweating, and hunger. Afrezza also carries a boxed warning, which is the strongest warning issued by the FDA. This warning highlights the risk of acute bronchospasm in patients with asthma or COPD. It is crucial to inform your healthcare provider if you have any lung conditions before starting Afrezza. In addition to these warnings, it is important to disclose all medical conditions, including liver or kidney problems, as well as any medications (including over-the-counter products and herbal supplements) that you are taking, to your healthcare provider before starting Afrezza. This will help ensure that there are no potential interactions or contraindications. Overall, it is crucial to follow your healthcare provider's instructions and advice when taking Afrezza and to report any adverse effects or concerns promptly. Regular monitoring of blood sugar levels and ongoing communication with your healthcare team are essential for safe and effective use of this medication.

Afrezza is a brand-name insulin product that is approved by the FDA for the treatment of type 1 diabetes and type 2 diabetes. It is an inhalation powder that is used to help control blood sugar levels in individuals with diabetes. As with any medication, Afrezza can cause some side effects. The most common side effects reported by individuals using Afrezza include cough, sore throat, and headache. These side effects are usually mild and tend to resolve on their own. In some cases, Afrezza may cause more serious side effects. These can include low blood sugar (hypoglycemia), which may cause symptoms such as dizziness, confusion, sweating, and blurred vision. It's important to monitor blood sugar levels closely and seek medical attention if any signs of low blood sugar occur. Additionally, using Afrezza may also lead to allergic reactions in some individuals. Allergic reactions can manifest as difficulty breathing, swelling of the face, lips, tongue, or throat, and hives. If you experience any signs of an allergic reaction, it is important to seek immediate medical attention. It is important to discuss all potential side effects and risks with your healthcare provider before starting Afrezza or any other medication for diabetes. They will be able to provide you with personalized information based on your individual medical history and condition.

Afrezza is a brand-name insulin product that is used for the treatment of both type 1 and type 2 diabetes. It is a unique inhalable form of insulin that is taken through the lungs. Unlike traditional injectable insulin, Afrezza doesn't come in a liquid form. Instead, it is available as a dry powder that is inhaled using a special inhaler device. The active ingredient in Afrezza is human insulin. This is the same hormone that is naturally produced by the pancreas in order to regulate blood sugar levels. The inhaled form of insulin in Afrezza is designed to be rapidly absorbed into the bloodstream, mimicking the natural insulin response that occurs after a meal. Besides the active ingredient, Afrezza contains other excipients, which are substances that help to stabilize and deliver the medication. These excipients are lactose monohydrate, magnesium stearate, and sodium carbonate. It's important to note that Afrezza is not suitable for people with chronic lung diseases such as asthma or chronic obstructive pulmonary disease (COPD). As with any medication, it is important to follow the prescribed dosage and instructions provided by your healthcare provider. If you have any questions or concerns about Afrezza or its ingredients, it is always best to consult with your doctor or pharmacist for personalized advice.

Afrezza, a brand-name insulin product, should be stored carefully to maintain its effectiveness. It is crucial to follow the storage instructions provided by the manufacturer and your healthcare provider. Here are some general guidelines for storing Afrezza: 1. Temperature: Afrezza should be kept in a cool place, away from extreme temperatures. It is recommended to store it at room temperature between 68°F and 77°F (20°C and 25°C). Avoid exposing it to excessive heat or cold, as it can affect the potency of the medication. 2. Protection from light: Keep Afrezza away from direct light exposure. Store the medication in its original packaging or an opaque container to shield it from light. 3. Dry environment: Ensure that the storage area is dry, as moisture can impact the stability of the medication. Avoid storing it in places like bathrooms or kitchens where humidity levels may be higher. 4. Safe from children and pets: Always store Afrezza in a secure location that is out of the reach of children and pets. Medications should never be accessible to them, as they could accidentally ingest it. 5. Check expiration dates: Before using Afrezza, check the expiration date on the packaging. Expired medications should be properly disposed of and not used. It's important to consult with your healthcare provider or pharmacist for any specific storage instructions or recommendations for Afrezza. They will provide you with accurate information based on the specific formulation and requirements of the medication.